fashion -WSS

fashion

author：Wikipedia 2025-08-26 03:42:20 - browse：6396

The artificial womb, a device aiming to save infants born way too soon, is inching closer to being tested in humans.

The technology is close enough to reality that the Food and Drug Administration has decided to convene a two-day panel starting Tuesday to discuss how to best evaluate safety and effectiveness, as well as the ethical quandaries in running clinical trials. The second day will be closed to the public to shield trade secrets.

Several research teams are racing to build artificial placentas that replicate the uterine environment and give the very prematurely born a better shot at survival. A team at the Children’s Hospital of Philadelphia, led by Alan Flake, is the closest to human trials — their device is a bag filled with sterile fluid, which contains the fetus and is connected to tubes providing oxygen and nutrition.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Orchard's therapy for neuron disease in children wins FDA approval

focus

WSS

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Orchard's therapy for neuron disease in children wins FDA approval

Decentralized clinical trials need collaboration to achieve wider use

Stroke rates rising, especially in working

Louisiana bill approved classifying abortion pills as controlled substances

AstraZeneca to buy developer of next

focus

fashion

leisure time

As demand for Covid shots wanes, Moderna seeks its next success

Neuroscience’s long legacy of racism

Virginia high school admissions case could be legal follow

Louisiana bill approved classifying abortion pills as controlled substances

Cancer drug shortages should be causing more outrage

Lawsuit challenges CMS nursing home minimum staffing rule

Novavax promises a turnaround & Lilly roils the obesity market

Why some fertility treatments produce more boy babies

Heart attack and stroke risk calculators need revising

Leading voice in opioid treatment defends methadone clinic system

focus

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

App could help diagnose ear infections more accurately — and at home

Pharma’s losing bet in New Jersey

Asbestos, a deadly carcinogen, banned by EPA

CVS Caremark has created a new ploy: the drug ‘rebate credit’

Unmasking the 'centricity' illusion in clinical trials

focus

entertainment

hotspot

hotspot